Sandu Pharmaceuticals Limited has announced the approval of its unaudited financial results for the quarter and the half-year ended September 30, 2026. The Board of Directors reviewed and approved these results, which were prepared in compliance with Ind-AS standards. The company has also made these results and the accompanying limited review report available on its website.
Sandu Pharmaceuticals Announces Financial Results
Sandu Pharmaceuticals Limited convened a Board of Directors meeting on Saturday, November 14, 2026. During this meeting, the board discussed and approved the unaudited financial results for the quarter and half-year period that concluded on September 30, 2026. The financial statements were prepared in accordance with Ind-AS and have undergone a limited review by Dave & Dave Chartered Accountants.
Key Financial Highlights
The approved financial results reflect the company’s performance up to September 30, 2026. The unaudited financial results, along with the limited review report, have been officially placed before the Board and taken on record. These documents are now accessible to the public on the company’s official website, www.sandu.in, and have been enclosed with this announcement for perusal.
Balance Sheet and Cash Flow Insights
The standalone balance sheet as of September 30, 2026, shows total assets of ₹5717.67 lakhs, with equity and liabilities totaling the same amount. Key assets include property, plant, and equipment totaling ₹848.22 lakhs, and inventories amounting to ₹1133.48 lakhs. Equity share capital stands at ₹966.10 lakhs, with other equity at ₹3435.20 lakhs.
The standalone statement of cash flow for the period ended September 30, 2026, indicates a net cash outflow from operating activities of ₹209.98 lakhs. Cash generated from operations before tax was ₹178.67 lakhs. The net cash outflow from investing activities was ₹40.32 lakhs, primarily due to purchases of property, plant, and equipment. Financing activities resulted in a net cash outflow of ₹106.84 lakhs, mainly from dividend payments.
Source: BSE
